These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1988519)

  • 21. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.
    Adluri S; Helling F; Ogata S; Zhang S; Itzkowitz SH; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1995 Sep; 41(3):185-92. PubMed ID: 7553688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential use of monoclonal antibodies as therapeutic modalities in neonatal infection.
    Hill HR; Gonzales LA; Kelsey DK; Raff HV
    Clin Rev Allergy; 1992; 10(1-2):29-38. PubMed ID: 1606522
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
    Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
    J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.
    Oishi K; Koles NL; Guelde G; Pollack M
    J Infect Dis; 1992 Jan; 165(1):34-45. PubMed ID: 1727896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.
    Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC
    Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO; Jensen CL; Pincus SH; Hill HR
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV; Bradley C; Brady W; Donaldson K; Lipsich L; Maloney G; Shuford W; Walls M; Ward P; Wolff E
    J Infect Dis; 1991 Feb; 163(2):346-54. PubMed ID: 1988519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of specific antibody in neonatal bacterial infections: an overview.
    Anthony BF
    Pediatr Infect Dis; 1986; 5(3 Suppl):S164-7. PubMed ID: 3520499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial carbohydrates in neonatal sepsis: targets for immunotherapy.
    Raff HV
    Springer Semin Immunopathol; 1993; 15(2-3):173-81. PubMed ID: 8256196
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies.
    Fischer GW
    J Clin Immunol; 1990 Nov; 10(6 Suppl):40S-46S. PubMed ID: 2081788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial monoclonal antibodies and the dawn of a new era in the control of infection.
    Macario AJ; Conway de Macario E
    Surv Synth Pathol Res; 1984; 3(2):119-30. PubMed ID: 6438759
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.